BCL6 and ovarian carcinoma: Remarkably, WK369 significantly induced the upregulation of BCL6 target genes in vivo (Figure 6E), which is consistent with our in vitro data observed in ovarian cancer cells treated with WK369, confirming the BCL6 inhibitory effect of WK369 in vivo.